Zoetis Valuation

ZTS -- USA Stock  

USD 124.27  1.35  1.07%

Zoetis maintains prevalent Real Value of $123.67 per share. The last-minute price of the organization is $124.27. At this time the organization appears to be fairly valued. This module calculates value of Zoetis from examining the organization fundamentals such as Current Valuation of 62.7B, Profit Margin of 22.74% and Return On Asset of 12.56% as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we encourage to purchase undervalued securities and to sell overvalued securities since at some point equities prices and their ongoing real values will grow together.
Fairly Valued
September 22, 2019
Market Value
Real Value
Zoetis is very steady asset. Calculation of real value of Zoetis is based on 3 months time horizon. Increasing Zoetis time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
Zoetis Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    

Zoetis Market Cap

Zoetis is rated fifth in market capitalization category among related companies. Market capitalization of Drug Manufacturers - Specialty & Generic industry is at this time estimated at about 205.12 Billion. Zoetis totals roughly 57.14 Billion in market capitalization claiming about 28% of equities under Drug Manufacturers - Specialty & Generic industry.
Capitalization  Revenue  Total debt  Valuation  Workforce
Horizon     30 Days    Login   to change
Zoetis is rated below average in last dividend paid category among related companies. It is rated fifth in price to sales category among related companies fabricating about  14.32  of Price to Sales per Last Dividend Paid.

Valuation Basics

Zoetis Enterprise Value Fundamentals

Quick Ratio2.58
Earnings Quarterly Growth-3.40%
Revenue Growth9.30%
Payout Ratio20.49%
Enterprise Value To Ebitda26.94
Earnings Growth-2.50%
Enterprise Value To Revenue10.37
See also Your Current Watchlist. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Search macroaxis.com